To include your compound in the COVID-19 Resource Center, submit it here.

NMD raises €38M series A

NMD Pharma ApS (Aarhus, Denmark) raised €38 million ($46.6 million) in a tranched series A round

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE